Affordable Access


Avicenna Research Institute
Publication Date
  • Editorial
  • Education
  • Medicine


As our valued readers you may well be aware that, the Avicenna Journal of Medical Biotechnology (AJMB) has recently been approved by the Commission for the Accreditation and Improvement of Iranian Medical Journals (CAIMJ) in the Ministry of Health and Medical Education. The AJMB is now included in the final list of accredited scientific and research journals in Iran and articles published in the AJMB will receive the appropriate credits from all the research/teaching institutes and Universities throughout the country. This is a great news for all our readers, contributors and particularly members of the editorial board and associates whose efforts in the past two years have brought this recognition from the Ministry of Health and Medical Education. I hope such acknowledgement will further facilitate the submission of high quality articles from the researchers in Iran who are working in the field of Medical Biotechnology. I must also inform our dear readers that the AJMB in the past year has been abstracted/ indexed in the databases as follows: Google Scholar, Genamics JournalSeek, Index Copernicus, EBSCO, Academic Search Complete, Serials Solution, Ulrich′s Periodical Directory, Open J-Gate, Electronic Journals Library EZB, Scientific Information Database (SID), EMRmedex, IranMedex and Magiran. The AJMB will be added to further databases gradually as the number of published issues increases in the near future. Inclusion in the databases that index so many international journals in the field of medicine and medical biotechnology would certainly bring wider readership worldwide for the articles published in the AJMB. Therefore, I would like to invite all scientists worldwide who work in the field of Medical Biotechnology to submit their works for publication in the AJMB. We would like to consider this journal as an international journal rather than a journal of a particular geographical region. Ali M. Ardekani Editor-in-Chief

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times